135 related articles for article (PubMed ID: 22236746)
1. p16(INK4a) and ProEx C immunostains facilitate differential diagnosis of hyperchromatic crowded groups in liquid-based Papanicolaou tests with menstrual contamination.
Ge Y; Mody DR; Smith D; Anton R
Acta Cytol; 2012; 56(1):55-61. PubMed ID: 22236746
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.
Halloush RA; Akpolat I; Jim Zhai Q; Schwartz MR; Mody DR
Cancer; 2008 Dec; 114(6):474-80. PubMed ID: 19016301
[TBL] [Abstract][Full Text] [Related]
3. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
[TBL] [Abstract][Full Text] [Related]
4. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.
Badr RE; Walts AE; Chung F; Bose S
Am J Surg Pathol; 2008 Jun; 32(6):899-906. PubMed ID: 18425044
[TBL] [Abstract][Full Text] [Related]
5. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
6. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemistry of p16INK4a in liquid-based cervicovaginal specimens with modified Papanicolaou counterstaining.
Negri G; Moretto G; Menia E; Vittadello F; Kasal A; Mian C; Egarter-Vigl E
J Clin Pathol; 2006 Aug; 59(8):827-30. PubMed ID: 16467166
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
9. Adjunct p16(INK4a) immunohistochemistry aids the detection of high-grade squamous intraepithelial lesions in endocervical curettage specimens.
Shah AA; Jeffus SK; Zhao Z; Stoler MH; Stelow EB
Am J Clin Pathol; 2014 Mar; 141(3):342-7. PubMed ID: 24515761
[TBL] [Abstract][Full Text] [Related]
10. Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C).
Kelly D; Kincaid E; Fansler Z; Rosenthal DL; Clark DP
Cancer; 2006 Dec; 108(6):494-500. PubMed ID: 17063495
[TBL] [Abstract][Full Text] [Related]
11. Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.
Oberg TN; Kipp BR; Vrana JA; Bartholet MK; Fales CJ; Garcia R; McDonald AN; Rosas BL; Henry MR; Clayton AC
Diagn Cytopathol; 2010 Aug; 38(8):564-72. PubMed ID: 19937941
[TBL] [Abstract][Full Text] [Related]
12. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear.
Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
Acta Cytol; 2007; 51(5):755-66. PubMed ID: 17910346
[TBL] [Abstract][Full Text] [Related]
13. ProEx C immunocytochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASC-US) cytology: correlation study with histologic biopsy.
Siddiqui MT; Hornaman K; Cohen C; Nassar A
Arch Pathol Lab Med; 2008 Oct; 132(10):1648-52. PubMed ID: 18834224
[TBL] [Abstract][Full Text] [Related]
14. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
[TBL] [Abstract][Full Text] [Related]
16. Analysis of performance characteristics of five cell cycle-related immunohistochemical markers and human papillomavirus genotyping in the diagnosis of cervical squamous cell carcinoma precursor lesions.
Conesa-Zamora P; Trujillo-Santos J; Orantes-Casado FJ; Ortiz-Reina S; Torres-Moreno D; Pérez-Guillermo M
Anal Quant Cytol Histol; 2012 Feb; 34(1):49-55. PubMed ID: 22590819
[TBL] [Abstract][Full Text] [Related]
17. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology.
Shroyer KR; Homer P; Heinz D; Singh M
Cancer; 2006 Oct; 108(5):324-30. PubMed ID: 16937378
[TBL] [Abstract][Full Text] [Related]
18. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.
Redman R; Rufforny I; Liu C; Wilkinson EJ; Massoll NA
Arch Pathol Lab Med; 2008 May; 132(5):795-9. PubMed ID: 18466028
[TBL] [Abstract][Full Text] [Related]
19. p16(INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies.
Cheah PL; Looi LM; Teoh KH; Mun KS; Nazarina AR
Asian Pac J Cancer Prev; 2012; 13(2):469-72. PubMed ID: 22524808
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia.
Guo M; Hu L; Baliga M; He Z; Hughson MD
Am J Clin Pathol; 2004 Dec; 122(6):894-901. PubMed ID: 15539381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
